Wang YN - Search Results

1

Chronic kidney disease: Biomarker diagnosis to therapeutic targets.

Wang YN, Ma SX, Chen YY, Chen L, Liu BL, Liu QQ, Zhao YY. Wang YN, et al. Clin Chim Acta. 2019 Dec;499:54-63. doi: 10.1016/j.cca.2019.08.030. Epub 2019 Aug 30. Clin Chim Acta. 2019. PMID: 31476302 Review.

2

New insights into TGF-β/Smad signaling in tissue fibrosis.

Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND, Zhao YY. Hu HH, et al. Among authors: wang yn. Chem Biol Interact. 2018 Aug 25;292:76-83. doi: 10.1016/j.cbi.2018.07.008. Epub 2018 Jul 11. Chem Biol Interact. 2018. PMID: 30017632 Free article. Review.

3

Natural products for the prevention and treatment of kidney disease.

Chen DQ, Hu HH, Wang YN, Feng YL, Cao G, Zhao YY. Chen DQ, et al. Among authors: wang yn. Phytomedicine. 2018 Nov 15;50:50-60. doi: 10.1016/j.phymed.2018.09.182. Epub 2018 Sep 17. Phytomedicine. 2018. PMID: 30466992 Review.

4

Poricoic acid A activates AMPK to attenuate fibroblast activation and abnormal extracellular matrix remodelling in renal fibrosis.

Chen DQ, Wang YN, Vaziri ND, Chen L, Hu HH, Zhao YY. Chen DQ, et al. Among authors: wang yn. Phytomedicine. 2020 Jul;72:153232. doi: 10.1016/j.phymed.2020.153232. Epub 2020 May 17. Phytomedicine. 2020. PMID: 32460034

5

Alisol B 23-acetate attenuates CKD progression by regulating the renin-angiotensin system and gut-kidney axis.

Chen H, Wang MC, Chen YY, Chen L, Wang YN, Vaziri ND, Miao H, Zhao YY. Chen H, et al. Among authors: wang mc, wang yn. Ther Adv Chronic Dis. 2020 May 20;11:2040622320920025. doi: 10.1177/2040622320920025. eCollection 2020. Ther Adv Chronic Dis. 2020. PMID: 32547719 Free PMC article.

6

Redox signaling and Alzheimer's disease: from pathomechanism insights to biomarker discovery and therapy strategy.

Chen YY, Wang MC, Wang YN, Hu HH, Liu QQ, Liu HJ, Zhao YY. Chen YY, et al. Among authors: wang mc, wang yn. Biomark Res. 2020 Sep 11;8:42. doi: 10.1186/s40364-020-00218-z. eCollection 2020. Biomark Res. 2020. PMID: 32944245 Free PMC article. Review.

7

Metabolomics in renal cell carcinoma: From biomarker identification to pathomechanism insights.

Chen YY, Hu HH, Wang YN, Liu JR, Liu HJ, Liu JL, Zhao YY. Chen YY, et al. Among authors: wang yn. Arch Biochem Biophys. 2020 Nov 30;695:108623. doi: 10.1016/j.abb.2020.108623. Epub 2020 Oct 8. Arch Biochem Biophys. 2020. PMID: 33039388 Review.

8

Poricoic acid A as a modulator of TPH-1 expression inhibits renal fibrosis via modulating protein stability of β-catenin and β-catenin-mediated transcription.

Chen DQ, Wu XQ, Chen L, Hu HH, Wang YN, Zhao YY. Chen DQ, et al. Among authors: wang yn. Ther Adv Chronic Dis. 2020 Sep 30;11:2040622320962648. doi: 10.1177/2040622320962648. eCollection 2020. Ther Adv Chronic Dis. 2020. PMID: 33062239 Free PMC article.

9

Deciphering the cellular mechanisms underlying fibrosis-associated diseases and therapeutic avenues.

Miao H, Wu XQ, Zhang DD, Wang YN, Guo Y, Li P, Xiong Q, Zhao YY. Miao H, et al. Among authors: wang yn. Pharmacol Res. 2021 Jan;163:105316. doi: 10.1016/j.phrs.2020.105316. Epub 2020 Nov 25. Pharmacol Res. 2021. PMID: 33248198 Review.

10

Long non-coding RNAs: A double-edged sword in aging kidney and renal disease.

Wang YN, Yang CE, Zhang DD, Chen YY, Yu XY, Zhao YY, Miao H. Wang YN, et al. Chem Biol Interact. 2021 Mar 1;337:109396. doi: 10.1016/j.cbi.2021.109396. Epub 2021 Jan 25. Chem Biol Interact. 2021. PMID: 33508306 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,589 results

Search Page

Filters